£14 million funding for major long-term science studies

December 10, 2015

Three high-value, long-term research projects totalling £13.9M have been awarded funding by the Biotechnology and Biological Sciences Research Council (BBSRC).

They have the potential to produce cheap and effective vaccines for poultry, develop plants that can make their own fertiliser and create new ways to breed elite lines of wheat.

The three grants, funded through BBSRC's Strategic Longer and Larger grants (sLoLas) scheme, give world-leading research teams five years of funding and resources to address major challenges.

The projects were chosen based on their scientific excellence; because they required long timescales, extensive resources; and because they involve internationally leading research teams.

Universities and Science Minister Jo Johnson said: "From better vaccines for livestock to growing higher-yield crops, Government is investing in these long-term projects to help the UK's world-leading scientists find innovative and sustainable solutions that will boost food production across the country."

Professor Jackie Hunter, BBSRC Chief Executive, said: "The BBSRC sLoLa scheme gives extra time and resources to world-leading UK scientists so they can address major scientific challenges.

"The funded studies include work to breed new varieties of wheat, improve the supply of biological nitrogen to plants and to create safe and cheap vaccines for poultry.

"As well helping the UK and the world to meet these challenges and offer economic and social benefit, the projects will develop the world-leading research capacity of the UK."

The projects are:

Professor Martin Buck, Imperial College London, Managing the Nitrogen economy of bacteria £4,579,656

Professor Keith Edwards, University of Bristol, Releasing natural variation in bread wheat by modulating meiotic crossovers £3,680,716

Professor Brendan Wren, London School of Hygiene and Tropical Medicine, Glycoengineering of Veterinary Vaccines £5,724,037
-end-
Contact:

Chris Melvin, BBSRC Media Officer, 01793 414694, chris.melvin@bbsrc.ac.uk

About BBSRC

The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, BBSRC invested over £509M in world-class bioscience in 2014-15. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact see: http://www.bbsrc.ac.uk

For more information about BBSRC strategically funded institutes see: http://www.bbsrc.ac.uk/institutes

Biotechnology and Biological Sciences Research Council

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.